Biofi lms can be defi ned as communities of microorganisms attached to a surface. Those bacterial biofi lms cause serious problems, such as antibiotic resistance and medical devicerelated infections. Nontypeable Haemophilus infl uenzae (NTHi) is an important pathogen in respiratory infections, as it forms biofi lms both in vitro and in vivo such as human middle ear. Recent reports indicate that otitis media, paranasal sinusitis and lower respiratory tract infections caused by Haemophilus infl uenzae have become more diffi cult to treat with oral antibiotic therapy. However, there has been no attention given to antibiotic eradication of NTHi biofi lm. To investigate the antimicrobial effect of various antibiotics against NTHi biofi lm formation, we conducted the following comparative study using both β -lactamase-negative ampicillin (AMP)-susceptible (BLNAS) and AMP-resistant (BLNAR) NTHi strains. In a microtiter biofi lm assay, both levofl oxacin and gatifl oxacin, of the fl uoroquinolone antibiotic group, signifi cantly inhibited biofi lm formation by BLNAS and BLNAR NTHi in a dose-dependent fashion compared to ampicillin of the penicillin antibiotic group, cefotaxime of the cephalosporin antibiotic group, and both erythromycin and clarithromycin of the macrolide antibiotic group. Furthermore, in fl ow cell chamber studies, confocal laser scanning microscopy counted survival bacteria in mature biofi lm had been treated with gatifl oxacin, ampicillin, cefotaxime and erythromycin. Only gatifl oxacin completely killed the BLNAR NTHi isolates within biofi lms without regard to the thickness of biofi lm formation. The results of this study suggest that fl uoroquinolones potentially have a role in therapy against diseases caused by both BLNAS and BLNAR NTHi isolates within biofi lms.
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MATERIALS AND METHODS

Bacterial strains and culture conditions
The H99 and H01 strains were clinical isolates obtained from different patients with respiratory tract infections. Before this experiment, microtiter biofi lm assay was performed in each of approximately 20 BLNAS and 20 BLNAR strains obtained from different patients. The H99 and H01 strains were selected, because these strains had formed biofi lms equally well. NTHi strains were reconstituted from frozen stocks and propagated on brain heart infusion (BHI) agar, or medium (Difco Laboratories, Detroit, MI, USA) supplemented with 10 μ g/ml of hemin (Sigma Chemical Co., St. Louis, MO, USA) and 10 μ g/ml of β -nicotinamideadenine nucleotide (β -NAD) (Sigma) at 37°C and 5% CO 2 (Anderson et al. 1972) .
Serotyping and PCR
H99 and H01 strains were serotyped by slide agglutination with antisera purchased from Difco Laboratories (Detroit, MI, USA). PCR was carried out for H. infl uenzae isolates by using mixed primers including the following (Wakunaga Pharmaceutical Co., Hiroshima): P6 primers to amplify the p6 gene, which encodes the P6 membrane protein specifi c for H. infl uenzae; TEM-1 primers to amplify a part of the β -lactamase (bla) TEM-1 gene; pbp3-1 primers to identify the same substitution as the low-BLNAR strains in the fts I gene; and pbp 3-2 primers to identify the same substitution as the BLNAR strains in the fts I gene (Hasegawa et al. 2004) .
Antimicrobial susceptibility test
Minimum Inhibitory Concentrations (MICs) were determined using a broth microdilution method, according to guidelines from the Clinical and Laboratory Standards Institute (2007) . Susceptibility of NTHi strains to the following 6 antibiotics was evaluated: ampicillin (AMP, Wako Pure Chemical Industries, Ltd., Osaka), cefotaxime (CTX, Wako), erythromycin (ERY, Dainippon Pharmaceutical Co., Osaka), clarithromycin (CLR, Abbott Japan Co., Tokyo), levofl oxacin (LVX, Daiichi Sankyo Co., Ltd., Tokyo) and gatifl oxacin (GAT, Kyorin Pharmaceutical Co., Tokyo). The antibiotics evaluated were those commonly approved for the treatment of bacterial infections from NTHi. Nontypeable Haemophilus infl uenzae (H. infl uenzae) is a gram-negative, pleomorphic bacterium that colonizes the human nasopharynx. NTHi can cause a variety of infections, including otitis media, sinusitis, conjunctivitis, bronchitis, and pneumonia (Murphy and Apicella 1987; Koyama et al. 2007 ). Recent reports state that β -lactamase-negative ampicillin (AMP)-resistant (BLNAR) strains have increased in some countries (Suzuki et al. 2003; Castanheira et al. 2006; Sunakawa and Farrell 2007) , although their global prevalence remains low (Hoban and Felminghan 2002) . Resistance in BLNAR strains results from mutations in the ftsI gene-encoding, penicillinbinding protein ( pbp) 3, which mediates septal peptidoglycan synthesis (Hasegawa et al. 2004) . Recent reports indicate that otitis media, paranasal sinusitis and lower respiratory tract infection caused by H. infl uenzae have become more diffi cult to treat with oral antibiotics therapy (Kaczmarek et al. 2004) .
Biofi lm is a structured community of bacterial cells enveloped in a self-produced, extrapolymeric matrix that is adherent to surfaces (Costerton et al. 1999; O'Toole et al. 2000) . Bacterial biofi lms are recognized as important causes of a variety of human infections, including infections of prosthetic devices, endocarditis, dental caries, pneumonia in cystic fi brosis, prostatitis and others (Singh et al. 2000; Donlan et al. 2001) . It is well known that bacteria within biofi lms are more resistant to antibiotic therapy than are planktonic organisms (Slinger et al. 2006) . In order to develop strategies for the treatment of infections caused by bacteria in biofi lms, including otitis media, it is important to elucidate the characteristics of bacterial pathogens within biofi lms.
Recent reports state that NTHi forms biofi lms both in vitro and in vivo, suggesting that biofi lm formation in vivo might play an important role in the pathogenesis and chronicity of otitis media (Greiner et al. 2004; Jurcisek et al. 2005; Hall-Stoodley et al. 2006) . Very little information is available concerning the effectiveness of various antimicrobials for the eradication of NTHi within biofi lms. The aim of our study is to evaluate the antimicrobial effect of a variety of antibi-
Microtiter biofi lm assay
Biofi lm formation in the H99 and H01 strains were assessed using a 96-well microplate, as previously described (Murphy and Kirkham 2002; Greiner et al. 2004) . After being cultured for 48 hrs, the biofi lms were exposed for 1 hr to differing concentrations (0.1 x MIC, 1 x MIC and 10 x MIC) of each antibiotics (AMP, CTX, ERY, CLR, LVX and GAT) solution every 12 hrs for 2 days (totally 4 doses). The evaluation of biofi lm was performed immediately after the fi nal exposure to the antibiotics solution. The culture medium containing planktonic cells was stained with 1% crystal violet at room temperature. After rinsing with water three times, the dye bound to the biofi lm was extracted with 230 μ l of 95% ethanol for 15 min. The extracted dye was quantifi ed by measuring the absorbance at 600 nm (OD600) with a microplate reader. The strains were tested in quadruplicate for each experiment and the results were reported as three different experiments.
Biofi lm growth in continuous fl ow cell chamber
Biofi lms were formed in continuous fl ow cell chambers as described by Davies et al. (1998) . The BLNAR H01 strain was grown in RPMI 1640 medium (Gibco BRI, Grand Island, NY, USA) supplemented with 1 μ g/ml of protoporphyrin IX which is hemin without iron, 0.1 mg/ml of hypoxanthine, 0.1 mg/ml of uracil, 10 μ g/ml of β -NAD, 0.8 mM of sodium pyruvate and 100 μ M sialic acid, or supplemented BHI medium. The culture was diluted to an optical density (OD) of 0.15 at 600 nm and supplemented with RPMI 1640 medium. The cell suspensions of 1 × 10 8 colony-forming unit (cfu) /ml was used to inoculate a 37 × 5 × 5 mm fl ow cell chamber, fi lled with the prepared inoculum and incubated at 37°C for 1 hr to allow adherence to the glass coverslips (Seib et al. 2007) . The chambers were then incubated for 48 hrs under 125 μ l/min fl ow in supplemented fresh RPMI 1640 or BHI medium diluted 1:10 with sterile phosphate-buffered saline (PBS). After being cultured for 48 hrs, the biofi lms were exposed for 1 hr to differing concentrations (0.1 x MIC, 1 x MIC and 10 x MIC) of each antibiotics (AMP, CTX, ERY and GAT) solution every 12 hrs for 2 days (totally 4 doses). After each exposure, the medium-containing antibiotic was replaced w i t h f r e s h m e d i u m c o n t a i n i n g n o a n t i b i o t i c . Approximately 5 hrs after the fi nal exposure to antibiotic solution, the biofi lms were tested using a Dead/Live BacLight viability stain kit (Molecular Probes, Eugene, OR, USA), following the manufacturer's protocol, by counting the colonies.
Colony counting NTHi isolates within biofi lms
To determine the antimicrobial effect of each antibiotics against NTHi isolates within biofi lms, colony counting was performed after 48 hrs. To collect bacteria from the culture, the biofi lms were removed from the fl ow chambers by fl ushing twice with 1 ml of sterile PBS at the end of each experiment. These washes were combined and aliquots (0.1 ml) of the suspension that had been subjected to serial 10-fold dilutions. These aliquots were sub-cultured onto supplemented BHI agars incubated at 37°C. The resultant colonies were counted to determine surviving colony-forming units (n = 3) at 48 hrs.
Quantifi cation of biofi lm structures
To evaluate the viability of biofi lm structure after exposure to antibiotics, the biofi lm formations were analysed by COMSTAT (BioCentrum-DTU, Lungby, Denmark) (Heydorn et al. 2000; Seib et al. 2007 ). COMSTAT is a program for quantifi cation of threedimensional biofi lm structures. It analyzes stacks of images acquired with confocal laser scanning microscopy (CLSM). First, biofi lms were stained using a Live/ Dead BacLight bacterial viability stain kit (Molecular Probs, Eugene, OR, USA). This permits visualization of live and dead bacteria within the biofi lms. Briefl y, SYTO 9 and propidium iodide were mixed at a 1:1 ratio in sterile PBS solution. The staining solution was introduced into the chamber for 15 min at 37°C in the dark. Biofi lm bacteria within the chamber were immediately visualized with CLSM (Nicon DIGITAL ECLIPSE C1, Nikon, Melville, NY, USA) using a modifi ed stage. Three independent biofi lm experiments were performed and at least four stacked images at 200 x magnifi cation per experiment were obtained and average values were used for statistical analyses. Each of the four stacked images was selected from an apical surface area at random in the chamber and examined. The threshold value that best fi t all image stacks of a trial was chosen and kept consistent for all stacks within the trial. Images were acquired at 2.0 μ m intervals down through the biofi lm Z-stack (μ m). Therefore, the number of images in each stack varied according to the biomass and average thickness of the biofi lm (Starner et al. 2006) . Quantifi cation of biofi lm biomass and average thickness was calculated using a MatLab 5.3 (The MathWork, Inc., Natick, MA, USA), equipped with an Image Processing Toolbox and COMSTAT analysis. The image stacks of "without" and "with" following exposure to each concentration of the antibiotic medium groups were averaged and compared.
Statistical tests and data analysis
All analyses of statistical signifi cance were performed with one-tailed Student's t-tests using Microsoft Excel (Microsoft Corp., Redmond, WA, USA). P values less than were considered statistically signifi cant. For quantifi cation of biofi lm mass, each datapoint used was the mean biomass of four randomly imaged areas from a single biofi lm. Mean biomass values from different biofi lm experiments were used for further statistical analyses (Starner et al. 2006) .
RESULTS
Characteristics of strains
The H99 and H01 strains used in this study are listed in Table 1 . The H99 and H01 strain were both nontypeable as assayed by slide agglutination with antisera. The MIC of H99 against AMP was 0.06 mg/l and H99 did not have the mutation of pbp 3-1 and pbp 3-2 by PCR, whereas the MIC of H01 against AMP was 1.0 mg/l and H01 had the mutation of pbp 3-1 and pbp 3-2 by PCR. As a result, it was determined that H99 was a BLNAS and H01 was a BLNAR strain.
Antimicrobial effect of antibiotics against BLNAS and BLNAR NTHi biofi lms by microtiter biofi lm assay
The antimicrobial effect of 6 antibiotics against BLNAS and BLNAR NTHi biofi lms were measured by microtiter biofi lm assay (Fig. 1) . As can be seen, 1 x and 10 x MIC of CTX, and 10 x MIC of CLR signifi cantly inhibited only the BLNAS (H99) NTHi biofi lm. By comparison, 1 x and 10 x MIC of LVX and GAT inhibited both the BLNAS (H99) and BLNAR (H01) NTHi biofi lms (Fig. 1) .
GAT completely kills BLNAR strain within biofi lms
Using a fl ow-cell system, the antimicrobial effects of various antibiotics against the BLNAR (H01) strain within biofi lms were evaluated after exposure to 0.1 x, 1 x and 10 x MIC of AMP, CTX, ERY and GAT (Fig. 2) . AMP, ERY and CTX had no effect on viability at any concentration. However, the effect of GAT against the BLNAR (H01) strain within biofi lms was dosedependent and, under the concentration of 10 x MIC, killed completely. Qualitative evaluation using CLSM indicated that the total biomass of the biofi lm exposed to each concentration of AMP and CTX were signifi cantly higher than that of GAT (Fig. 3A) as assayed by COMSTAT software. Biofi lms treated with GAT had a significantly lower ( p = 0.001) total biomass than those treated with AMP and CTX. The total biomass of the biofi lm after exposure to 0.1 x and 1,0 x MICs of ERY tended to be lower than that of GAT but not signifi cantly lower , however, the total biomass of the 10 x MIC ERY treated biofi lm was signifi cantly higher ( p = 0.001) than that of GAT. The average thickness of all the biofi lms was similar whether or not the organisms were treated with antibiotics (Fig. 3B ).
DISCUSSION
NTHi is one of the most prevalent pathogens associated with respiratory tract infections and thus acquisition of antimicrobial resistance raises concern. The prevalence of BLNAR strains was reported to be 2.4% in the USA between 2002 and 2003 (Heilmann et al. 2005 ) and 9.3% in Spain between 1998 and 1999 (Marco et al. 2001) . Their global prevalence of BLNAR strains remains relatively low. However, the prevalence of BLNAR in Japan has increased rapidly, from 5.8% in 2000 to 34.5% in 2004, even in H. infl u- Ampicillin, erythromycin and cefotaxime had no effect on viability at any concentration, whereas the effect of gatifl oxacin against the BLNAR strain within biofi lms was dose-dependent and, under the concentration of 10 x MIC, killed completely. Results are given as average of 3 replicates ± S.D. *p < 0.001 as compared with the strain without exposure to antibiotics. enzae type b isolated from patients with meningitis (Hasegawa et al. 2004 ). The result has been an increasing number of cases of otitis media, which are diffi cult to treat, and an increasing incidence of treatment failures with oral antibiotics in young children (Starner et al. 2006 ). This is due in large part to antibiotic resistance, which points to a need for oral therapy to change along with surgical management of tympanostomy or tympanostomy tubes (Casey et al. 2004 ). However, the pathogenesis of NTHi infection of airway cells involves both an intracellular life cycle as well as biofi lm formation on the surface of the airway epithelia. Therefore, because NTHi invade human bronchial epithelial cells by macropinocytosis (Ketterer et al. 1999 ) and form biofi lms both in vitro and in vivo (Greiner et al. 2004; Jurcisek et al. 2005; Hall-Stoodley et al. 2006) , it is not clear whether drug resistance alone causes treatment diffi culty and failure in otitis media among young children. To our knowledge, the antimicrobial effect of antibiotics against NTHi within biofi lms remains unclear. Our data show that LVX and GAT have signifi cant inhibitory effect against both BLNAS and BLNAR NTHi within biofi lms compared to AMP, CTX, ERY and CLR. Our results agree with previous investigations that studied P. aeruginosa biofi lm, as it has been shown that fl uoroquinolones can penetrate exopolysaccharides (Kumon et al. 1994; Yassien et al. 1995) . Since the use of fl uoroquinolones in young children is limited in many countries because of adverse neurological side effects, the clinical antimicrobial effectiveness against BLNAS and BLNAR NTHi in biofi lms has not been confi rmed. AMP, CTX, ERY and CLR had no signifi cant effect against either BLNAS or BLNAR NTHi biofi lms, although it has been reported that macrolides have an inhibitory effect on P. aeruginosa biofi lm formation and survival cells in biofi lm (Favre-Bonté et al. 2003; Nalca et al. 2006 ).
There may be several limitations in the present study. First, only single BLNAS and BLNAR strains were investigated, although the biofi lm formation among each of 20 BLNAS and 20 BLNAR strains were investigated before these studies and these two strains were selected. The second limitation is a lack of in vivo data.
In conclusion, our data demonstrate that fl uoroquinolones could be effective therapeutic agents against biofi lm diseases caused by both BLNAS and BLNAR NTHi. Further investigations, such as the chinchilla otitis media model or Biofi lms exposed to gatifl oxacin had a signifi cantly lower total biomass than those to ampicillin and cefotaxime. The total biomass of the biofi lms after exposure to 0.1 x and 1.0 x MICs of erythromycin tended to be lower than that of gatifl oxacin, but the total biomass of the 10 x MIC erythromycin treated biofi lm was signifi cantly higher than that of gatifl oxacin. The average thickness of all of the biofi lms was similar whether or not the organisms were treated with antibiotics. *p < 0.001 as compared with the strain exposed to without antibiotics.
clinical trial to determine the in vivo antimicrobial effect of fl uoroquinolones on NTHi biofi lms should be considered.
